A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were randomised to receive either sequential therapy with three cycles of ifosfamide followed by three cycles of carboplatin, or to six cycles of single a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Perren, T. J., Wiltshaw, E., Harper, P., Slevin, M., Stein, R., Tan, S., Gore, M., Fryatt, I. J., Blake, P. R.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1993
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968655/
https://ncbi.nlm.nih.gov/pubmed/8260372
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires